ZIOP - ZIOPHARM Oncology - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $2.61. This is a potential upside of $2.61 (0%) from yesterday's end of day stock price of $0.

ZIOPHARM Oncology's activity chart (see below) currently has 4 price targets and 6 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by DAVID NOVAK from RAYMOND JAMES on 10-Aug-2021. First documented stock forecast 26-Mar-2013.

Best performing analysts who are covering ZIOP - ZIOPHARM Oncology:

Jim Birchenough David Novak Chris Howerton Thomas Flaten

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

3

$2.17 (261.45%)

2 years 11 months 4 days ago

0/2 (0%)

$0.74 (31.70%)

Buy

7

$6.17 (743.37%)

7

2 years 11 months 4 days ago

0/3 (0%)

$3.8 (144.78%)

Buy

5

$4.17 (502.41%)

7

3 years 4 months 2 days ago

0/2 (0%)

$2.17 (63.99%)

Hold

15

9 years 22 days ago

0/4 (0%)

$3.74 (33.21%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ZIOP (ZIOPHARM Oncology) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ZIOP (ZIOPHARM Oncology) with a proven track record?

JIM BIRCHENOUGH

Which analyst has the current lower performing score on ZIOP (ZIOPHARM Oncology) with a proven track record?

THOMAS FLATEN

Which analyst has the most public recommendations on ZIOP (ZIOPHARM Oncology)?

Jim Birchenough works at WELLS FARGO and has 10 price targets and 4 ratings on ZIOP

Which analyst is the currently most bullish on ZIOP (ZIOPHARM Oncology)?

Thomas Flaten with highest potential upside - $6.17

Which analyst is the currently most reserved on ZIOP (ZIOPHARM Oncology)?

Jim Birchenough with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?